Insider trades
Robert Barrow, CEO of Definium Therapeutics DFTX, has filed 2 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $3.3M. The latest trade was on 09/25.
Robert Barrow
CEO
- Company
- Definium Therapeutics DFTX
- First filing
- 23/03/02
- Trades
- 24 trades
- Buys / sales
- 2 / 17
- 12-month net buying
- −$3.3M
- Last trade
- 09/25
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 09/25 | 09/29 | 31,550 sh | $36.57 | $1,153,783.5 | −1.4% | |
| Open-market sale10b5-1 plan | 06/25 | 06/26 | 29,208 sh | $45.03 | $1,315,236.24 | −2.6% | |
| Open-market sale10b5-1 plan | 03/25 | 03/26 | 24,431 sh | $18.47 | $451,240.57 | −3.1% | |
| Open-market sale10b5-1 plan | 25/12/26 | 25/12/29 | 25,791 sh | $13.15 | $339,151.65 | −3.2% | |
| Open-market sale10b5-1 plan | 25/09/25 | 25/09/26 | 25,797 sh | $9.77 | $252,036.69 | −3.1% | |
| Open-market sale10b5-1 plan | 25/06/25 | 25/06/26 | 26,491 sh | $6.80 | $180,138.8 | −3.1% | |
| Open-market sale10b5-1 plan | 25/03/25 | 25/03/26 | 21,208 sh | $6.74 | $142,941.92 | −2.4% | |
| Open-market sale10b5-1 plan | 24/12/26 | 24/12/27 | 19,106 sh | $7.43 | $141,957.58 | −3.5% | |
| Open-market sale10b5-1 plan | 24/09/25 | 24/09/25 | 19,771 sh | $5.98 | $118,230.58 | −3.5% | |
DFTX | Open-market buy | 24/08/19–24/08/20 | 24/08/20 | 1,000 sh2 trades | $6.22avg. | $6,215 | +0.2% |
| Open-market sale10b5-1 plan | 24/06/25 | 24/06/25 | 15,659 sh | $7.22 | $113,057.98 | −2.7% | |
| Open-market sale10b5-1 plan | 24/03/25 | 24/03/26 | 16,519 sh | $9.50 | $156,930.5 | −2.8% | |
| Open-market sale | 23/12/26 | 23/12/26 | 13,237 sh | $3.63 | $48,050.31 | −2.2% | |
DFTX | Open-market sale | 23/09/25 | 23/09/25 | 13,499 sh2 trades | $3.58avg. | $48,273.74 | −2.2% |
DFTX | Open-market sale | 23/06/27 | 23/06/27 | 15,502 sh2 trades | $3.20avg. | $49,619.7 | −2.4% |
| Open-market sale | 23/03/01 | 23/03/02 | 8,273 sh | $3.51 | $29,038.23 | −3.3% |